What a Combined Gilead and Incyte Would Look Like
Gilead Sciences has long been in need of a catalyst to move its business, and a lot of investors and analysts alike have considered this company dead money until something happens.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 174
Prescription Drug Misuse Hits 70% of American Workplaces
Prescription drug misuse has spread so much that it is a problem in over 70% of American workplaces, according a new survey by the National Safety Council.
Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal
Valeant Pharmaceuticals announced that it intends to refinance some of its debt. One key analyst thinks that this might be a sign to abandon ship.
Monday’s Top Health Care Stocks Screaming Higher
Markets may be slowing down and taking a step back after hitting new highs in what has been known as the Trump rally. Still, a few stocks in the health care sector were are…
Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy
In this week's top stock picks from Jefferies, three very prominent biotechnology stocks are featured, including one that is a large cap leader.
Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
Why Analysts Are Looking at Valeant Pharma Differently After Earnings
Valeant Pharmaceuticals shares hit a multiyear low this past week, and some analysts took this opportunity to reevaluate their stance on the stock.
Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential
Here are three biotech companies that not only have data that could prove to be huge, but their shares have been absolutely hammered over the last year, offering aggressive accounts the best entry points…
Thursday’s Top Biopharma Movers
Opko Health and a few other biopharma companies made massive runs on Thursday.
RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates
Each year, the analysts at RBC come out with a detailed list of smaller companies they feel are targets for acquisitions. These four health care candidates look extremely attractive.
4 Biopharma Stocks Moving the Market on Wednesday
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
Why Valeant Missed the Mark Despite an Earnings Beat
Valeant Pharmaceuticals reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Short Sellers Hike Their Bets in Major Biotechs
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
Why Short Sellers Are Making a Massive Bet in Major Pharma
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
How La Jolla’s Low Blood Pressure Treatment Is Driving New Highs
La Jolla Pharmaceutical saw its shares skyrocket on Monday after top-line results from its late-stage study of patients with catecholamine resistant hypotension.